Atlas Trials

ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

Clinical trial NCT03897543 · RECRUITING

Trial details

NCT number
NCT03897543
Sponsor
Abivax S.A.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Carcinoma, Hepatocellular
Start date
2019-08-30
Primary completion
2021-06-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.